Medical Devices Startups

FBGS manufactures fiber optic sensing components including Fiber Bragg Gratings, interrogators, and custom sensors for applications in medical, aerospace, civil engineering, telecommunications, and research sectors.

1 investor

FDNA develops AI-powered diagnosis and care management tools that help parents, clinicians, and researchers identify developmental delays and rare genetic disorders early. The company serves patients, families, healthcare providers, and the pharmaceutical industry across 130+ countries using facial image analysis and genetic health risk assessment technology.

1 investor

FEMTOPRINT develops ultrafast 3D laser microfabrication technology for glass microdevices. The company serves customers in glass micro-manufacturing with deep expertise in precision processing.

1 investor

Fennec Pharmaceuticals develops treatments for cisplatin-induced hearing loss, a side effect of cancer chemotherapy. The company serves cancer patients undergoing treatment with cisplatin-based drugs.

1 investor

Ferric Contrast develops iron-based MRI contrast agents intended to produce high-quality magnetic resonance images of the brain, vasculature, liver, kidneys, and cancer-related tumors. The company positions its agents as safer diagnostic tools for use by physicians.

1 investor

Ferrosan Medical Devices manufactures medical devices used in surgical procedures with a focus on product quality, safety, and improved surgical outcomes. The company operates with sustainability commitments across environmental, social, and governance areas, including renewable energy use and emission reduction targets.

1 investor

Fertiga is a biotech company that develops diagnostic tools to improve IVF success rates. The company's Aurora niPCT™ is a non-invasive diagnostic tool designed to identify the most viable oocytes for fertility treatments, with a mission to make assisted reproduction more effective and accessible.

1 investor

Fertilis designs precision medical devices for in vitro fertilization (IVF) procedures, specifically instruments that reduce mechanical stress on embryos and reduce the technical burden on embryologists. The company develops tools to enhance embryologist expertise and improve clinical outcomes rather than replace human expertise in fertility treatment.

1 investor

FertilAI develops artificial intelligence technologies to improve fertility treatment decision-making for clinicians. The company serves fertility specialists seeking to enhance patient outcomes through advanced computational tools.

1 investor

Fiagon develops electromagnetic navigation systems for surgeons in ENT (ear, nose, throat), neurosurgery, and spine procedures. The company provides user-friendly integrated navigation solutions that enable precise real-time tracking of surgical instruments.

1 investor

Field Trip Health provides ketamine-assisted therapy for treatment-resistant depression and anxiety, offering rapid symptom relief through clinically monitored ketamine administration combined with psychotherapy. The company operates clinics in the US and Canada where ketamine is legally approved for therapeutic use.

1 investor

FieldCure develops iMET, an electric field-based cancer therapy device that applies alternating electric fields at specific frequencies to disrupt mitosis in cancer cells while sparing normal cells. The system includes 64-channel electrode control and an AI-based treatment planning system for patient-specific optimization, targeting intractable cancers such as pancreatic cancer.

1 investor

Fieldy is a HIPAA-compliant wearable device that captures and transcribes patient conversations into medical notes for healthcare professionals. The device uses AI to generate summaries, extract action items, and automatically organize clinical documentation across over 100 languages.

1 investor

Find Therapeutics is a clinical-stage biopharmaceutical company developing therapies to treat demyelinating diseases, particularly multiple sclerosis and related conditions affecting myelin repair. The company was founded in 2020 and is based in Canada with backing from multiple life sciences investors.

1 investor

First Ascent Biomedical provides personalized cancer treatment recommendations using a proprietary live-cell testing platform that evaluates individual tumor response to 150+ FDA-approved therapies. The company serves oncologists and cancer patients, delivering treatment insights within approximately 10 days to enable faster, more effective care decisions.

1 investor

FIZE Medical develops an automated digital platform for fluid management in clinical settings, using real-time data to support clinical decision-making. Its FIZE kUO system aims to provide precise measurement of patient fluid outputs to enable earlier intervention.

1 investor

Flexpoint manufactures sensors and interactive devices, including bend sensors, battery expansion sensors, occupant detection systems, and specialized controls for automotive, medical, industrial, and consumer applications.

1 investor

Flomatrix is a medical technology company developing patented IV catheter tip technology designed to reduce the mechanical forces on veins that cause inflammation, blockages, and early cannula failure. It serves the vascular access market, aiming to extend clinical dwell time of IV cannulas and lower failure-related costs.

1 investor

Flomics develops liquid biopsy tests using next-generation sequencing and machine learning to detect cancer and other complex diseases from blood samples for clinical diagnostics. The company also provides end-to-end genomics solutions including data generation, analysis, and bioinformatics support for research and clinical projects.

1 investor

Flonics develops medical imaging software that automates blood flow analysis using MRI technology for diagnosis and management of cardiovascular and cerebrovascular diseases. The platform provides automated image acquisition, analysis, and reporting alongside a virtual catheter tool to replace invasive procedures.

1 investor

Floracene provides independent surgery centers with software to identify lower-cost clinically equivalent orthopedic and spine implants based on their existing manufacturer contracts. The platform helps physician-owners reduce implant costs by presenting alternative options that meet clinical requirements for specific procedures.

1 investor

Flourish Research operates a network of clinical trial research sites specializing in patient recruitment and retention across therapeutic areas including cardiometabolic disease, neuroscience, oncology, and infectious diseases. The company serves pharmaceutical sponsors and contract research organizations (CROs) by providing integrated site infrastructure, patient access, and standardized operations for studies across all research phases.

1 investor

Flow provides a consumer-facing neurostimulation device using transcranial direct current stimulation (tDCS) for depression treatment. The technology is clinically validated and available for at-home use to balance activity in mood-regulating brain regions.

1 investor

flowbone develops a first-in-class injectable bioactive hydrogel that triggers the body to deposit its own minerals and form new bone, aimed at preventing osteoporotic hip fractures. It is a preclinical-stage medical technology company spun off from EPFL's Laboratory of Biomechanical Orthopedics, with products still in development.

1 investor